AI assistant
Sending…
GENTEX CORP — Director's Dealing 2025
May 19, 2025
30893_dirs_2025-05-19_8ab0f80b-d329-4b1e-bae2-1d89a90a6236.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2025-05-15
Reporting Person: ANDERSON JOSEPH B JR (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-15 | Common Stock | A | 5939.00 | $0.00 | Acquired | 9703.00 | Direct |
| 2025-05-16 | Common Stock | S | 3764.00 | $22.8683 | Disposed | 5939.00 | Direct |
Footnotes
F1: These shares vest 100% one year from grant award date.
F2: This transaction was executed in multiple trades ranging from $22.65 to $23.07. The price reported above reflects the weighted average price.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19